This document provides EU/EEA Member States with evidence-based scientific advice on available options, when planning and implementing prevention and control interventions for blood-borne viruses in prison settings.
People in prison experience a higher burden of communicable diseases such as hepatitis B (HBV), hepatitis C (HCV) and HIV often linked to a history of injecting drug use.
This guidance is intended for policymakers responsible for the planning and delivery of healthcare services in the national or sub-national custodial system and all professionals responsible for the health and well-being of people in prison, including community-based service providers and those facilitating continuity of care in the community.
The objective of this report was to systematically review data on prevention and control of BBVs in prison settings, with a focus on the countries of the European Union (EU) and the European Economic Area (EEA).
This ECDC study protocol describes the technical requirements for implementing future EU-level genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae.
Between 13 and 19 July 2018, six cases of human West Nile fever were reported in the EU by Greece (3), Romania (2) and Hungary (1). In neighbouring EU countries, 18 cases were reported by Serbia.
Between 13 and 19 July 2018, six cases of human West Nile fever were reported in the EU by Greece (3), Romania (2) and Hungary (1). In neighbouring EU countries, 18 cases were reported by Serbia. This week, two outbreaks among equids were reported: one in Greece and another in Italy.